ClinicalTrials.gg
DrugSupplement

Alpha-Linolenic Acid clinical trials

Also written ALA 10%.

studies test it
10
open now
1
in phase 3
1
first study started
2009

Counted the way a researcher would: Alpha-Linolenic Acid with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses alpha-Linolenic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the alpha-Linolenic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

ALA 5%
2

Development codes

ALA 10%
2

Other names

Alpha Linolenic Acid
1

Studies by the year they started

10 studies that test it; most in 2019 (2)

Studies that test alpha-Linolenic Acid, by start year
YearStudies
20091
20101
20151
20171
20192
20211
20221
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
3
Phase 3
1
Phase 4
1
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 8

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (2) · The University of Texas Health Science Center, Houston (1) · Northwestern University (1) · Merete Haedersdal (1) · Yonsei University (1) · Hadassah Medical Organization (1) · Michal Schnaider Beeri, Ph.D. (1) · University of California, San Francisco (1)

Often tested with

Tested in the same studies.

Urea (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test alpha-Linolenic Acid.

Studies

Open first, then newest update. How each study uses alpha-Linolenic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 10

Given beside what is tested · 1 — alpha-Linolenic Acid is usual care or a partner of the new treatment

Codes

What other systems call alpha-Linolenic Acid · ClinicalTrials.gg INT008619

  • MeSH (NLM) D017962alpha-Linolenic AcidConfirmed NLM, Wikidata
  • UNII (FDA) 0RBV727H71LINOLENIC ACIDConfirmed FDA, NLM, Wikidata
  • RxNorm 52071Confirmed FDA, Wikidata
  • Wikidata Q256502alpha-linolenic acidConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C997Linolenic AcidOne source FDA
  • DrugBank DB00132One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.